Skip to main content
. 2023 Jun 28;28(13):5056. doi: 10.3390/molecules28135056

Table 2.

Experimental conditions for several antibiotics.

Antibiotic Column Type Mobile Phase Program’s Elution Detector References
Cefpiramide
and relative
impurities
1D: Kromasil C8
analytical column (250 mm × 4.6 mm,
5 µm).
2D: Shimadzu
Shim-pack GISS C18 analytical column (124 mm × 2.1 mm, 1.9 µm).
1D: (A) 30 mM phosphate/methanol (75:25, v/v) and (B) phosphate buffer (30 mM, pH 7.5)/methanol (50:50, v/v) / 2D: (A)
ammonium
formate
solution (10 mM) and (B) methanol.
1D: gradient conditions:
Time (min) B%
0            0
12          0
32          100
33          0
The mobile phase flow rate was 0.80 mL/min.
2D: gradient conditions:
Time (min) B%
0                5
5                95
5.5–9          5
The mobile phase flow rate was 0.30 mL/min.
Ion trap/time-of- flight mass
spectrometer (Shimadzu Corp., Kyoto,
Japan), equipped with an electrospray ionization (ESI) source in positive and negative mode.
[39]
Polymerized impurities of cephalosporins:
cefodizime, cefmenoxime, and cefonicid
1D: Xtimate SEC-120 analytical column (7.8 mm × 30 cm, 5 m).
2D: Method A: Shimadzu Shim-pack GISS C18 analytical column (50 mm × 2.1 mm, 1.9 m).

Method B/C: ZORBAX SB-C18 analytical column
(4.6 × 150 mm, 3.5 m).
1D: (A) 0.005 mol/L dibasic sodium phosphate solution and (Β) 0.005 mol/L sodium dihydrogen phosphate solution (61:39, v/v)] acetonitrile v/v)].

2D: Method A: (A) ammonium formate solution (10 mM) and (B) acetonitrile.

Method B: (A) acetic acid solution (0.1%, v/v) and (B) acetonitrile.
Method C: (A) ammonium formate solution (10 mM) and (B) ammonium formate (8 mM) in [acetonitrile/water


(4:1, v/v)] solution.
1D: gradient conditions:
Time (min) B%
0            5
18          20
20          5
The mobile phase’s flow
rate was 0.80 mL/min and the injection volume was 30 μL.

2D: gradient elution
Method A:
Time (min) B%
0                5
5                95
5.5–9          5

Method B:
Time (min) B%
0            5
12          15
45          60
55          5

Method C:
Time (min) B%
0            12
9            16
15          20
18          40
19          12
The mobile phase flow rate was 0.40 mL/min.
Ion trap/time-of- flight mass
spectrometer (Shimadzu Corp., Kyoto, Japan), equipped with an
electrospray ionization (ESI) source in positive and negative mode.
[41]
Impurities in
cefonicid sodium
1D: GRACE Alltima C18 analytical column (250 mm × 4.6 mm, 5 μm)/2D: Shimadzu Shim-pack GISS C18
analytical column (50 mm × 2.1 mm, 1.9 μm).
1D: (A) 0.02 mol·L−1
ammonium
dihydrogen phosphate
solution in H2O with 40% aqueous ammonia solution) and (B) methanol.

2D: (A) 10 mmol·L−1 ammonium formate
solution and (B) methanol.
1D gradient elution:
Time (min) B%
0–10            16
10–30          60
41                16
The mobile phase flow rate was 0.80 mL/min.

2D gradient elution:
Time (min) B%
0                5
5                95
5.5–9          5
The mobile phase flow rate was 0.30 mL·min−1.
Ion trap/time-of- flight mass spectrometer (Shimadzu Corp., Kyoto,
Japan), equipped with an electrospray ionization (ESI) source in positive and negative mode.
[40]
Meropenem 1D: Shim-Pack CLC ODS (6 mm × 150 mm, 5 μm, Shimadzu, Kyoto, Japan)/2D: Shim-pack GISS C18 column (50 mm × 2.1 mm, 1.9 μm, Shimadzu, Kyoto, Japan) used at 40 °C. 1D: (A) 0.1% triethylamine/acetonitrile (96:4, v/v) and (B) 0.1% triethylamine/acetonitrile (70:30, v/v) / 2D: (A) 10 mM ammonium
formate and (Β) methanol.
1D: Gradient elution
Time (min) B%
0            0
18          10
55          60
56          0
The flow rate was 1.5 mL·min−1.

2D: Gradient elution mode:
Time (min) B%
0                5
5                95
5.5–9          5
The flow rate was 0.30 mL min−1.
Ion trap/time-of- flight mass spectrometer (Shimadzu Corp., Kyoto, Japan), equipped with an electrospray ionization (ESI) source in positive and negative mode. [43]
Amoxicillin
1D: Shim-pack GIS C18 (4.6 mm × 250 mm, 5 μm)/2D: Shim-pack GIS C18(4.6 mm × 150 mm, 5 μm). 1D: ammonium dihydrogen phosphate/tetrahydrofuran/methanol (730∶12.5∶300) /
2D: 1% formic acid aqueous solution (A)/acetonitrile (B).
Isocratic conditions: the flow rate was 1 mL/min. UV detector at 254 nm. [46]
Benzylpenicillin, Flucloxacillin,
Amoxicillin
Riperacillin,
the beta-lactamase inhibitors Clavulanic acid and Clindamycin,
Macrolide
antibiotics, and Tazobactam clindamycin
1D: XBridge® C8
Direct Connect HP column (10 µm
particle size, 2.1 × 30 mm)/2D: Acquity UPLC® BEH C18 (1.7 µm particle size,
2.1 × 100 mm i.d.; Waters) analytical column equipped with an Acquity UPLC® BEH C18 VanGuard precolumn (1.7 µm
particle size, 2.1 × 5 mm i.d.; Waters).
1D: 100% H2O with 0.1% formic acid/2D: (A) water containing 0.1% formic acid and (B) acetonitrile containing 0.1% formic acid. 1D: Isocratic elusion at a flow rate of 1.0 mL/min.

2D: Gradient elution
Time (min) B%
0.0          10
1.8          10
4.5          45
5.0          100
6.0          100
6.1          10
The flow rate was 700 µL/min.
A triple-quadrupole mass spectrometer (TSQ ENDURA) (Thermo Scientific, Reinach,
Switzerland), equipped with an electrospray
ionization source in
positive mode.
[44]
Vancomycin 1D: Reversed-phase Diamonsil C18(2) column
(100 mm × 4.6 mm,
5 μm, China; C1).

Middle column: a strong cation-exchange column (20 mm × 4.6 mm, 5 μm, ANAX, China; MC).

2D: Inertsil ODS-3 column (150 mm × 4.6 mm, 5 μm, GL Science Inc., Japan; C2).
1D: (A) 20 mmol/L
ammonium
acetate buffer and (Β) acetonitrile (88:12, v/v)/
2D: (A) 50.0 mmol/L
Ammonium
acetate buffer
(pH 5.0) and (B)
acetonitrile (85:15, v/v), mobile phase C.
1D: isocratic elusion with a flow rate of (A)
1.2 mL/min, (Β) 1.6 mL/min, and (C) 1.5 mL/min.
UV detector at 282 nm. [42]
Amoxicillin, cloxacillin, oxacillin, and linezolid 1D: Perfusion column (POROS R1/20, 20 m, 2.1 mm × 30 mm, Applied Biosystems, Darmstadt, Germany)/2D:
Pentafluorophenyl (PFP) analytical column (Phenomenex Kinetex, 2.6 m, 2 mm × 50 mm, Aschaffenburg,
Germany).
1D: (A) water + 0.1% formic acid, (B) MeOH + 0.1% formic acid, (C) water/10 mM ammonium formate, with formic acid, and (D) ACN + 0.1% formic acid. Isocratic conditions: a flow rate of 4.0 mL/min over 0.70 min.


Gradient conditions:
Time (min) D%
0               10
0.75          10
3.20          98
3.80          10
3.81          10
A TQD triple-quadrupole mass spectrometer) equipped with an
electrospray
ionization source (Waters, St Quentin, France) in positive mode.
[45]
Sulfonamides,
Beta-agonists,
and (Steroid) hormones
Self-made: 1D: Waters HSS Cyano
(1.8 µm, 1 × 150 mm), Waters BEH C18 (1.8 µm, 1 × 150 mm), Waters
Phenyl (1.8 µm, 1 × 150 mm) and a
Phenomenex
Kinetix
(2.6 µm, 1.0 × 150 mm) column.

2D: Waters Phenyl column
(1.7 µm, 2.1 × 50 mm).

Commercial
LC × LC
1D: (A) water/acetonitrile (90:10) containing 0.1% formic acid and (Β) water/acetonitrile (10:90)
containing 0.1% formic acid.

2D: (A) water/acetonitrile (90:10) containing 0.1% formic acid and (B) water/acetonitrile (10:90)
containing 0.1% formic acid.
1D gradient conditions:
Time (min) B%
0            80
27          80
28          0

2D gradient conditions:
Time (min) B%
0            0
45          40
50          100
Ion trap/time-of- flight mass
spectrometer
(Waldbronn,
Germany), was equipped with an electrospray ionization (ESI) source in positive mode.
[48]
The polymerized impurities in cefotaxime sodium and cefepime

2D HPSEC/RP-HPLC system

2D RP-HPLC/RP-HPLC system
1D: a TSK-gel G2000SWxl column (7.8 mm × 30 cm, 5 μm) from TOSOH Corporation
(Tokyo, Japan).

2D: Agilent ZORBAX SB-C18 analytical column (4.6 mm × 150 mm, 3.5 μm) (Santa Clara, CA, USA).

1D: Kromasil (Nouryon, Bohus, Sweden) 100-5-C18 analytical column (4.6 mm × 250 mm, 5 μm).

2D: Shimadzu Shim-pack GISS C18 analytical column (50 mm × 2.1 mm, 1.9 μm)
1D: phosphate buffer of dibasic sodium
phosphate
solution/0.005 mol/L sodium
dihydrogen
phosphate
solution, 61:39 (v/v), and
acetonitrile at 95:5 (v/v).

2D: (A) 10 mM ammonium formate solution and (B) acetonitrile.

1D: For cefotaxime sodium
injection, the mobile phases were 0.05 M disodium hydrogen
phosphate
solution (A) and methanol (B).

For cefepime, the mobile phases were 0.05 M
ammonium
dihydrogen
phosphate
solution (A) and
acetonitrile (B).


2D: (A) 10 mM ammonium
formate solution and (B) acetonitrile.
1D: Isocratic conditions: a flow rate of 0.50 mL/min

2D: Gradient elution
Time (min) B%
0–20            5
20–21          40
21–29          5

The flow rate of the mobile phase was 0.40 mL/min.

1D for cefotaxime,
gradient elution:
Time (min) B%
0–10            15
10–30          15
30–40          70
40–41          70
41–50          15
The flow rate was 0.8 mL/min and the
injection volume was 20 μL.


1D for cefepime: the gradient program was set as follows:
Time (min) B%
0                 10
10               10
30               70
40               70
41–50         10
The flow rate was 1.00 mL/min.

2D, gradient conditions:
Time (min) B%
0–5            5–95
5.5–5.5       5
1D: PDA detector in the range of
200–400 nm.

2D: UV detection wavelength of 254 nm.


1D: PDA detector in the range of
200–400 nm.

2D: Ion trap/time-of-flight mass spectrometer (Shimadzu Corp., Kyoto,
Japan), equipped with an
electrospray ionization (ESI) source in positive and
negative mode.
[41]